Tandem Diabetes Care, Inc.
NASDAQ:TNDMMedical - Devices
+$0.24 today
- Market cap
- $1.19B
- Beta
- 1.57
- P/E (TTM)
- -11.3
- EPS (TTM)
- -$1.38
Volume 2.35M
Average 2.43M
TNDM Deferred Revenue (Non-current)
Payments received for goods or services the company will deliver after more than one year.
Tandem Diabetes Care, Inc.NASDAQ: TNDM
Deferred Revenue (Non-current) · Q1 FY2026 · quarter ended Mar 2026
Deferred revenue (non-current) falls 18.9% from a year ago
Deferred revenue (non-current) stood at $7.99M at the end of Q1 FY2026, down 18.9% from a year earlier and down 5.7% from the prior quarter. Over 3 fiscal years it compounded at -20.5% a year.
Context
- Deferred revenue (non-current) amounted to 0.7% of total assets at the end of Q1 FY2026, down 0.4 pp from a year earlier.
- Deferred revenue (non-current) increased in 0 of the last 3 fiscal years.
- FY2025 was the lowest annual figure in the 4 fiscal years shown.
What to watch
Whether deferred revenue (non-current) keeps falling in the next quarterly balance sheet after a -18.9% change from a year earlier.
Sources:Balance SheetText generated from reported figures; not investment advice.
Deferred Revenue (Non-current) history
USD · from the balance sheet
- Latest · FY2025
- 8.47M USD
- Year-over-year change
- -18.9%
- 4-year CAGR
- -15.9%
| Period | Period end | Deferred Revenue (Non-current) | YoY change |
|---|---|---|---|
| FY2025 | 2025-12-31 | 8.47M | -18.9% |
| FY2024 | 2024-12-31 | 10.46M | -21.6% |
| FY2023 | 2023-12-31 | 13.33M | -21.0% |
| FY2022 | 2022-12-31 | 16.87M | -0.4% |
| FY2021 | 2021-12-31 | 16.94M | — |
Deferred Revenue (Non-current) vs competitors
How TNDM compares with its peers on the latest reported figures
- TNDM's Mar 2026 deferred revenue (non-current) of $7.99M is the 2nd highest of the 8 companies compared; the peer median is $2.1M.
- Its year-over-year change of -18.9% is the 4th highest of 5, against a peer median of +13.0%.
- Deferred revenue (non-current) amounts to 0.7% of total assets for TNDM, versus a peer median of 0.1%.
| Company | Period | Latest balance | YoY | 3-year CAGR | % of assets |
|---|---|---|---|---|---|
| Mar 2026 | $38.91M | -17.9% | +2.0% | 5.2% | |
| Mar 2026 | $7.99M | -18.9% | -20.5% | 0.7% | |
MMEDMiniMed Group, Inc. Common Stock | Jul 2026 | $5M | — | — | 0.1% |
| Mar 2026 | $3.35M | +43.8% | — | 1.1% | |
| Jun 2026 | $2.1M | +50.0% | -2.1% | 0.1% | |
| Jun 2026 | $0 | -100.0% | — | 0.0% | |
| Mar 2026 | $0 | — | — | 0.0% | |
| Mar 2026 | $0 | — | — | 0.0% | |
MMEDVMiniMed Group, Inc. | — | — | — | — | — |
| Peer median (excluding TNDM) | $2.1M | +13.0% | -0.1% | 0.1% | |
Competitors are the stored peer set for TNDM. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.
Balance Sheet
Metric | FY2021 Dec 2021 | FY2022 Dec 2022 | FY2023 Dec 2023 | FY2024 Dec 2024 | FY2025 Dec 2025 |
|---|---|---|---|---|---|
| Cash & Equivalents | 71.18M | 172.52M | 58.87M | 69.23M | 90.63M |
| Short-term Investments | 552.63M | 444.38M | 409.04M | 369.1M | 202.03M |
| Net Receivables | 110.73M | 114.72M | 105.56M | 114.59M | 165.49M |
| Inventory | 68.55M | 111.12M | 157.94M | 149.61M | 128.77M |
| Other Current Assets | 0 | 7.24M | 16.59M | 21.97M | 31.22M |
| Total Current Assets | 811.52M | 849.98M | 747.99M | 724.49M | 618.14M |
| Property, Plant & Equipment (Net) | 77.89M | 179.18M | 164.33M | 163.46M | 179.75M |
| Goodwill | 0 | 0 | 0 | 0 | 0 |
| Intangible Assets | 6.64M | 4.63M | 2.78M | 925K | 0 |
| Long-term Investments | 0 | 0 | 0 | 74.55M | 60.35M |
| Tax Assets | 0 | 0 | 0 | 0 | 0 |
| Other Non-current Assets | 9.09M | 19M | 37.56M | 4.24M | 22.87M |
| Total Non-current Assets | 93.62M | 202.81M | 204.67M | 243.17M | 262.97M |
| Total Assets | 905.14M | 1.05B | 952.66M | 967.66M | 881.11M |
| Account Payables | 28.03M | 55.73M | 49.59M | 44.73M | 47.07M |
| Short-term Debt | 0 | 0 | 0 | 40.67M | 0 |
| Tax Payables | 0 | 0 | 0 | 0 | 0 |
| Deferred Revenue | 10.18M | 18.84M | 43.99M | 11.83M | 9.53M |
| Other Current Liabilities | 74.94M | 68.01M | 71.89M | 47.08M | 145.65M |
| Total Current Liabilities | 131.86M | 165.29M | 195.26M | 247.05M | 242.72M |
| Long-term Debt | 281.47M | 283.23M | 285.04M | 308.27M | 310.04M |
| Deferred Tax Liabilities | 0 | 0 | 0 | 0 | 0 |
| Deferred Revenue (Non-current) | 16.94M | 16.87M | 13.33M | 10.46M | 8.47M |
| Other Non-current Liabilities | 17.84M | 23.92M | 31.83M | 32.37M | 49.74M |
| Total Non-current Liabilities | 340.17M | 447.55M | 443.77M | 457.51M | 483.22M |
| Total Liabilities | 472.03M | 612.84M | 639.03M | 704.56M | 725.94M |
| Common Stock | 64K | 65K | 66K | 66K | 68K |
| Retained Earnings | (634.6M) | (729.19M) | (951.8M) | (1.05B) | (1.25B) |
| Accumulated OCI | (616K) | (1.82M) | 1.37M | (1.95M) | 5.59M |
| Other Stockholders Equity | 0 | 0 | 0 | 0 | 0 |
| Minority Interest | 0 | 0 | 0 | 0 | 0 |
| Total Equity | 433.11M | 439.95M | 313.63M | 263.1M | 155.17M |
| Total Debt | 314.67M | 419.88M | 415.67M | 473.57M | 444.48M |
| Net Debt | 243.49M | 247.36M | 356.8M | 404.33M | 353.84M |
Tandem Diabetes Care, Inc.
NASDAQ:TNDM
Intrinsic Alpha fair value
Locked
Current Price
$17.05
Unlock the intrinsic value to see where the current price sits on the valuation runway.
Valuation runway
LockedGet the intrinsic value and margin of safety with a free account.
Continue the stock analysis
Jump to another research area for this company.